Caffeine in Your Blood Could Affect Body Fat And Diabetes Risk, Study Reveals
The levels of caffeine in your blood could affect the amount of body fat you carry, a factor that in turn could determine your risk of developing type 2 diabetes and cardiovascular diseases.
Those are the findings of a 2023 study that used genetic markers to establish a more definitive link between caffeine levels, BMI, and type 2 diabetes risk.
The research team, from the Karolinska Institute in Sweden, the University of Bristol in the UK, and Imperial College London in the UK, said calorie-free caffeinated drinks could be explored as a potential means of helping reduce body fat levels.
"Genetically predicted higher plasma caffeine concentrations were associated with lower BMI and whole body fat mass," the researchers wrote in their paper, published in March 2023.
"Furthermore, genetically predicted higher plasma caffeine concentrations were associated with a lower risk of type 2 diabetes. Approximately half of the effect of caffeine on type 2 diabetes liability was estimated to be mediated through BMI reduction."
The study involved data from just under 10,000 people collected from existing genetic databases, focusing on variations in or near specific genes known to be associated with the speed at which caffeine is broken down.
In general, those with variations affecting the genes – namely CYP1A2 and a gene that regulates it, called AHR – tend to break caffeine down more slowly, allowing it to remain in the blood longer. Yet they also tend to drink less caffeine in general.
An approach called Mendelian randomization was used to determine likely causal relationships between the presence of the variations, illnesses like diabetes, body mass, and lifestyle factors.
While there was a significant link between caffeine levels, BMI, and type 2 diabetes risk, no relationship emerged between the amount of caffeine in the blood and cardiovascular diseases including atrial fibrillation, heart failure, and stroke.
Previous studies have linked a moderate and relative increase in caffeine consumption to better heart health and a lower BMI, and this research adds more detail to what we already know about the effects that coffee has on the body.
It's important to also keep in mind the impacts of caffeine on the body aren't all positive, which means care must be taken when weighing up the benefits of drinking it – but this latest study is an important step in assessing how much caffeine is ideal.
"Small, short term trials have shown that caffeine intake results in weight and fat mass reduction, but the long term effects of caffeine intake is unknown," the researchers explained.
"Considering the extensive intake of caffeine worldwide, even its small metabolic effects could have important health implications."
The team thinks the association shown here could be down to the way caffeine increases thermogenesis (heat production) and fat oxidation (turning fat into energy) in the body, which both play an important role in overall metabolism.
While this study involved a large sample, Mendelian randomization isn't infallible, and it's still possible that other factors are at play that weren't accounted for. More research will be needed to confirm cause and effect.
"Randomized controlled trials are warranted to assess whether non-caloric caffeine containing beverages might play a role in reducing the risk of obesity and type 2 diabetes," said University of Bristol genetic epidemiologist Benjamin Woolf.
The research was published in BMJ Medicine.
An earlier version of this article was published in March 2023.
Leading Cause of Death in US Claims A Life Every 34 Seconds
Surprising Link Between Menthol And Alzheimer's Discovered in Mice
AI Can Predict Breast Cancer Risk Years Before Diagnosis, Study Finds

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a day ago
- Yahoo
Titan's Atmosphere 'Wobbles Like a Gyroscope' – And No One Knows Why
There's something very peculiar about the atmosphere surrounding Titan, Saturn's largest moon: rather than staying constantly fixed in line with its surface, the atmosphere wobbles across the course of the seasons. The discovery was made in new research led by a team from the University of Bristol in the UK, through a detailed analysis of 13 years' worth of infrared light readings. Gas composition and temperature can be interpreted from these readings, and from there the shifting position of the atmosphere. It's not clear yet what's causing the unusual behavior, but it could eventually lead to more insights about the history of Titan, and other planetary bodies that share similarities with it. That includes Earth, since both have a relatively thick atmosphere, liquid lakes, and weather patterns. "The behavior of Titan's atmospheric tilt is very strange," says planetary scientist Lucy Wright, from the University of Bristol. "Titan's atmosphere appears to be acting like a gyroscope, stabilizing itself in space." "Even more intriguingly, we've found that the size of this tilt changes with Titan's seasons." That seasonal shift suggests the tilt might have something to do with the moon's yearly cycle around the Sun, in tandem with Saturn. A year on Titan lasts almost 30 years on Earth, and comes with major changes in heating and temperature. However, while the magnitude of the atmospheric tilt changes, the direction it's pointing doesn't: it always remains directed towards the same fixed spot. Working out why is going to take some time and further research. "What's puzzling is how the tilt direction remains fixed in space, rather than being influenced by the Sun or Saturn," says planetary scientist Nick Teanby, from the University of Bristol. "That would've given us clues to the cause. Instead, we've got a new mystery on our hands." One hypothesis the team is considering is that there was a large impact event in Titan's past which caused the atmospheric wobbles to begin, bringing changes in the moon's climate along with them. This research has a very real practical and immediate use: the Dragonfly spacecraft is scheduled to pay a visit to Titan in 2034. Getting the probe to land successfully in the swirling winds of the Saturnian moon will need a precise understanding of its atmosphere. Once Dragonfly is in place, we can expect plenty more in the way of fascinating discoveries. The team behind this new study describes Titan as "one of the most intriguing bodies in the Solar System" because of its characteristics – including being the only moon in the Solar System to have a proper atmosphere. Titan could even enhance our understanding of how life might get started and survive on alien worlds, under the influence of an atmosphere like Titan's – something that future studies could investigate. "The fact that Titan's atmosphere behaves like a spinning top disconnected from its surface raises fascinating questions – not just for Titan, but for understanding atmospheric physics more broadly, including on Earth," says planetary scientist Conor Nixon, from the NASA Goddard Space Flight Center in Maryland. The research has been published in the Planetary Science Journal. A 'Crazy Idea' About Pluto Was Just Confirmed in a Scientific First A Giant Mouth Has Opened on The Sun And Even It Looks Surprised A Super-Tiny Star Gave Birth to a Giant Planet And We Don't Know How
Yahoo
2 days ago
- Yahoo
Women on blockbuster weight loss drugs warned to use effective contraception
Pregnant women should not take weight loss drugs, the UK's medicines regulator warned amid concerns that people are using the so-called 'skinny jabs' in unsafe ways. The UK Medicines and Healthcare products Regulatory Agency (MHRA) also said women should not take weight loss drugs if they are breastfeeding or trying to get pregnant, because there isn't enough safety data to know whether the medicine could affect their baby. 'Anyone who gets pregnant while using them should speak to their healthcare professional and stop the medicine as soon as possible,' the agency said. Meanwhile, all women taking the jabs should ensure they are using a form of contraception that works, the MHRA said. Related Weight-loss drugs like Wegovy could help serious liver condition that has no cure-all treatment One of the drugs, Mounjaro, may make birth control pills less effective, so the agency says women taking the jab should also use a non-oral form of contraception, like an implant or intrauterine device (IUD). 'Obesity reduces fertility in women. So, women with obesity taking GLP-1 drugs are more likely to get pregnant than before they lost weight,' Dr Channa Jayasena, a reproductive endocrinology researcher at Imperial College London, said in a statement. 'Women are advised to do all they can to prevent pregnancy while taking [these] drugs,' Jayasena added. Related France won't pay for weight loss drug Wegovy. What about other European countries? In the UK, women already receive these warnings when they get their prescriptions for the blockbuster jabs, which include Ozempic, Wegovy, Saxenda, and Victoza as well as Mounjaro. The drugs, known as GLP-1 receptor agonists, work by mimicking hormones that help regulate appetites and make people feel full for longer. They have been approved to treat type 2 diabetes and obesity. Related Why are 1 in 10 French women still smoking during pregnancy despite the health risks? But the MHRA issued the reminder Thursday due to concerns that the drugs' growing popularity means women are buying them illegally online or at beauty salons, without seeing a doctor. 'Skinny jabs are medicines licensed to treat specific medical conditions and should not be used as aesthetic or cosmetic treatments,' Dr Alison Cave, MHRA's chief safety officer, said in a statement. 'They are not a quick fix to lose weight and have not been assessed to be safe when used in this way,' she added.
Yahoo
2 days ago
- Yahoo
Women on blockbuster weight loss drugs warned to use effective contraception
Pregnant women should not take weight loss drugs, the UK's medicines regulator warned amid concerns that people are using the so-called 'skinny jabs' in unsafe ways. The UK Medicines and Healthcare products Regulatory Agency (MHRA) also said women should not take weight loss drugs if they are breastfeeding or trying to get pregnant, because there isn't enough safety data to know whether the medicine could affect their baby. 'Anyone who gets pregnant while using them should speak to their healthcare professional and stop the medicine as soon as possible,' the agency said. Meanwhile, all women taking the jabs should ensure they are using a form of contraception that works, the MHRA said. Related Weight-loss drugs like Wegovy could help serious liver condition that has no cure-all treatment One of the drugs, Mounjaro, may make birth control pills less effective, so the agency says women taking the jab should also use a non-oral form of contraception, like an implant or intrauterine device (IUD). 'Obesity reduces fertility in women. So, women with obesity taking GLP-1 drugs are more likely to get pregnant than before they lost weight,' Dr Channa Jayasena, a reproductive endocrinology researcher at Imperial College London, said in a statement. 'Women are advised to do all they can to prevent pregnancy while taking [these] drugs,' Jayasena added. Related France won't pay for weight loss drug Wegovy. What about other European countries? In the UK, women already receive these warnings when they get their prescriptions for the blockbuster jabs, which include Ozempic, Wegovy, Saxenda, and Victoza as well as Mounjaro. The drugs, known as GLP-1 receptor agonists, work by mimicking hormones that help regulate appetites and make people feel full for longer. They have been approved to treat type 2 diabetes and obesity. Related Why are 1 in 10 French women still smoking during pregnancy despite the health risks? But the MHRA issued the reminder Thursday due to concerns that the drugs' growing popularity means women are buying them illegally online or at beauty salons, without seeing a doctor. 'Skinny jabs are medicines licensed to treat specific medical conditions and should not be used as aesthetic or cosmetic treatments,' Dr Alison Cave, MHRA's chief safety officer, said in a statement. 'They are not a quick fix to lose weight and have not been assessed to be safe when used in this way,' she added.